Strive Health, founded in 2018, stands at the forefront of the Digital Health and Health Care sectors, emphasizing innovative Information Technology solutions for kidney care. Headquartered in the United States, the company leverages artificial intelligence and a unique technology platform, CareMultiplier™, to offer comprehensive care for chronic and end-stage kidney disease patients.
The company operates a value-based care model, collaborating with commercial and Medicare Advantage payors and over 6,500 providers to support more than 145,000 individuals across all 50 states. Accredited by the National Committee for Quality Assurance (NCQA), Strive ensures adherence to quality standards, enhancing patient outcomes and care delivery efficiency.
In its latest funding round, a $166.00M Series C investment raised on May 31, 2023, was backed by investors including New Enterprise Associates, Town Hall Ventures, Redpoint Ventures, CapitalG, Ascension Ventures, CVS Health, and Echo Health Ventures, reinforcing its position as an industry leader poised for continued growth and innovation.